<SEC-DOCUMENT>9999999995-26-001217.txt : 20260417
<SEC-HEADER>9999999995-26-001217.hdr.sgml : 20260417
<ACCEPTANCE-DATETIME>20260417001515
ACCESSION NUMBER:		9999999995-26-001217
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260416
DATE AS OF CHANGE:		20260417
EFFECTIVENESS DATE:		20260416

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kailera Therapeutics, Inc.
		CENTRAL INDEX KEY:			0002096997
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-294690
		FILM NUMBER:		26869298

	BUSINESS ADDRESS:	
		STREET 1:		180 THIRD AVENUE
		STREET 2:		4TH FLOOR
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		508-440-9475

	MAIL ADDRESS:	
		STREET 1:		180 THIRD AVENUE
		STREET 2:		4TH FLOOR
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0101</schemaVersion>

    <submissionType>EFFECT</submissionType>

    <act>33</act>

    <testOrLive>LIVE</testOrLive>

    <effectiveData>
        <finalEffectivenessDispDate>2026-04-16</finalEffectivenessDispDate>
        <finalEffectivenessDispTime>16:00:00</finalEffectivenessDispTime>
        <form>S-1</form>
        <filer>
            <cik>0002096997</cik>
            <entityName>Kailera Therapeutics, Inc.</entityName>
            <fileNumber>333-294690</fileNumber>
        </filer>
    </effectiveData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
